Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
0.97/5.98
|
|
Enterprise Value
21.42B
|
| Balance Sheet |
|
Book Value Per Share
-1.52
|
| Cash Flow |
|
Cash Flow Yield
0.60
|
| Income Statement |
|
Total Revenue
823.72M
|
|
Operating Revenue Per Share
23.05
|
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/11/07 13:27 EST
Industry overview quotes are at least 15 minutes delayed
|
Business Description
|
|||
| Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reportsrevenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment. |

6.62 
